We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BID:JSEBid Corporation Limited Analysis

Data as of 2026-07-18 - not real-time

ZAC 43,962.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Bid Corp is trading at roughly ZAc 43,962, comfortably above its 20‑day (ZAc 43,635), 50‑day (ZAc 42,456) and 200‑day (ZAc 41,980) simple moving averages, underscoring a short‑term bullish bias. The RSI sits at 57, indicating neutral momentum, while the MACD histogram is negative and the signal line is bearish, suggesting a potential near‑term pull‑back. Volatility over the past 30 days is moderate at about 18 % and the beta is low‑negative, pointing to limited sensitivity to broader market swings. The market sentiment index reads “Extreme Greed” (87.9), which may be inflating price enthusiasm.
Fundamentally, the company posted 7.1 % revenue growth, a solid ROE of 19 % and a dividend yield of 2.8 % with a comfortable payout ratio of 44 %. However, the discounted cash‑flow model values the stock at roughly ZAc 26,700, leaving the current price significantly overvalued. The upside/downside metric shows a modest 9 % premium, and the defensive consumer sector provides a low‑risk backdrop. Dividend sustainability appears strong given positive operating and free cash flow.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above all major SMAs supports bullish bias
  • Bearish MACD histogram warns of near‑term correction
  • Current valuation exceeds DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Steady revenue growth and strong ROE
  • Sustainable dividend with low payout ratio
  • Defensive consumer sector cushions earnings volatility

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant overvaluation relative to intrinsic value
  • Low beta and modest volatility reduce market risk
  • Diversified geographic footprint balances growth and risk

Key Metrics & Analysis

Financial Health

Revenue Growth7.10%
Profit Margin3.61%
P/E Ratio16.8
ROE19.32%
ROA7.35%
Debt/Equity52.22
P/B Ratio3.2
Op. Cash FlowZAC13.3B
Free Cash FlowZAC6.0B

Technical Analysis

TrendBullish
RSI57.4
SupportZAC 42,556.00
ResistanceZAC 44,865.00
MA 20ZAC 43,635.30
MA 50ZAC 42,456.02
MA 200ZAC 41,980.47
MACDBearish
VolumeDecreasing
Fear & Greed Index87.91

Valuation

Fair ValueZAC 26,685.23
Target PriceZAC 47,980.00
Upside/Downside9.14%
GradeOvervalued
TypeBlend
Dividend Yield2.79%

Risk Assessment

Beta-0.16
Volatility18.25%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.